IEPF

 
Year Document   Report

June 2020 List of shareholders (Erstwhile Shasun) Final Dividend FY2012-13 PDF 113 KB
April 2020 List of shareholders Final Dividend - FY 2012 PDF 128 KB
Sep 2019 List of shareholders - Final Divided – FY 2011-12 (relates to erstwhile Shasun) PDF 44 KB
June 2019 List of shareholders– Final Divided – FY 2011 PDF 62 KB
April 2019 List of shareholders (Erstwhile Shasun Pharmaceuticals) - Interim Divided – FY 2011-2012 PDF 59 KB
June 2018 List of shareholders (Erstwhile Shasun Pharmaceuticals) - for FY 2011 PDF 96 KB
March 2018 List of shareholders - relating to FY ending December 2010 PDF 92 KB
October 2017 List of Shareholders – transfer of shares to IEPF Account PDF 321 KB
Consolidated Unclaimed/ Unpaid Dividend Data

The Consolidated unclaimed/ unpaid dividend details as required by the Investor Education and Protection Fund (Uploading of information regarding unpaid and unclaimed amounts lying with companies) Rules, 2012, are provided herein below for all the unclaimed/unpaid dividend accounts outstanding for the respective financial years.


FY 2018 - 19

FY 2017 - 2018

FY 2016 - 2017

FY 2015 - 2016

 
FY 2014 - 2015

FY 2013 - 2014
Unclaimed Shares Suspense Account

Pursuant to Regulation 39(4) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 read with Schedule VI of the said Regulations, the Company has dematerialized shares which have been returned undelivered by postal authorities and shares lying unclaimed. The dematerialised shares are held in an ‘unclaimed suspense account’ opened with Karvy Stock Broking Limited.

Any corporate benefits accruing on such shares, viz. bonus shares, split etc., shall also be credited to unclaimed suspense account, for a period of seven years and thereafter shall be transferred by the Company to IEPF, in accordance with provisions of Section 124(5) and (6) of the Companies Act, 2013 and rules made thereunder.

In accordance with the provisions of the Listing Regulations, the Company reports the following details in respect of equity shares lying in the suspense account.

Particulars Number of shareholders Number of equity shares
Aggregate number of shareholders and the outstanding shares in the suspense account lying at the beginning of the year 1,193 71,225
Shareholders who approached the Company for transfer of shares from suspense account during the year 17 358
Shareholders to whom shares were transferred from the suspense account during the year 17 358
Aggregate number of shareholders and shares which were transferred to IEPF as per the MCA Circular 37 496
Aggregate number of shareholders and the outstanding shares in the suspense account lying as on March 31, 2019 1,139 70,371

The voting rights on the shares outstanding in the suspense account as on March 31, 2019 shall remain frozen till the rightful owner claims the shares.

Unpaid/ Unclaimed Dividends and Shares

In accordance with the provisions of Sections 124 and 125 of Companies Act, 2013 and Investor Education and Protection Fund (Accounting, Audit, Transfer and Refund) Rules, 2016 (IEPF Rules) dividends not encashed/ claimed within seven years from the date of declaration are to be transferred to the Investor Education and Protection Fund (IEPF) Authority.

The IEPF Rules mandate companies to transfer shares of Members whose dividends remain unpaid/ unclaimed for a continuous period of seven years to the demat account of IEPF Authority. The Members whose dividend/ shares are transferred to the IEPF Authority can claim their shares/ dividend from the Authority.

In accordance with the said IEPF Rules and its amendments, the Company had sent notices to all the Shareholders whose shares were due to be transferred to the IEPF Authority and simultaneously published newspaper advertisement.

In terms of the provisions of Investor Education and Protection Fund (Accounting, Audit, Transfer and Refund) Rules, 2016 Investor Education and Protection Fund (Awareness and Protection of Investors) Rules, 2001, 362,935/- of unpaid/ unclaimed dividends and 11,626 shares were transferred during FY 2018-19 to the IEPF including the dividend amounts declared and paid by erstwhile Shasun Pharmaceuticals Limited.

The Company has appointed Ms. Manjula Ramamurthy, Company Secretary as the Nodal Officer of the Company under the provisions of IEPF, the details of which are available on the website of the Company.

The Company has uploaded the details of unpaid and unclaimed amounts lying with the Company as on September 24, 2018 (date of last AGM) on the Company’s website.

Due date for transfer of unpaid/ unclaimed dividend to IEPF is as follows:

Financial Year Ending Type of Dividend Dividend
Rate
Date of declaration Due date for transfer to IEPF
31 Dec
2011
Final 20% 25 May 2012 30 June 2019
31 Dec
2012
Final 20% 10 June 2013 16 July 2020
31 Mar
2014
Special 5000% 10 Dec 2013 15 Jan 2021
Final 50% 9 Sepr 2014 15 Oct 2021
31 Mar
2015
Special 1050% 7 Oct 2014 12 Nov 2021
Final 30% 30 Jul 2015 04 Sep 2022
31 Mar
2016
Final 40% 29 Jul 2016 03 Sep 2023
31 Mar
2017
Final 45% 15 Sep 2017 21 Oct 2024
31 Mar
2018
Final 20% 24 Sep 2018 30 Oct 2025
Fractional Shares Account *
27 Jan
2016
NA NA NA 03 Mar 2023
Unclaimed Shares Suspense Account**
17 Aug
2016
NA NA NA 22 Sep 2023

* Arising on account of sale of fractional shares pursuant to merger of Shasun with Strides.

** Pursuant to unclaimed shares considered into Suspense Account as per Listing Regulations.

Due dates for transfer of unpaid/ unclaimed dividends to IEPF relating to erstwhile Shasun Pharmaceuticals Limited which got merged with the Company effective November 19, 2015 is as follows:

Financial Year Ending Type of Dividend Dividend Rate Date of declaration Due date for transfer to IEPF
31 Mar
2012
Final 20% 02 Aug 2012 07 September 2019
31 Mar
2013
Final 75% 02 Aug 2013 07 Sep 2020
31 Mar
2014
Final 50% 06 Aug 2014 11 Sep 2021
31 Mar
2015
Interim 50% 30 July 2015 04 Sep 2022

The Members of the Company, who have not yet encashed their divided warrant(s), may write to the Company/ Registrar and Share Transfer Agents immediately.

Dematerialization of Shares & Liquidity

The Company's shares are traded in dematerialised form. The Company has established connectivity with both the Depositories viz., National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL) through the Registrar, Karvy Fintech Private Limited.

As at March 31, 2019, 99.83% of the paid-up share capital of the Company representing 89,396,070 shares has been dematerialised and balance 0.17% representing 153,406 shares of the Company is in physical form.

Updation of PAN and Bank Details of Shareholders

Pursuant to SEBI circular bearing reference SEBI/HO/MIRSD/DOP1/CIR/P/2018/73 dated April 20, 2018, the Company through its Registrar and Transfer Agents has initiated collection of copies of PAN and bank account details of the shareholders holding shares in physical form.   

In this connection, Company has sent reminders to shareholders holding shares in physical form, requesting them to register/ update their PAN and bank account details. For ease of shareholders and effective updation, Company has provided postage paid/ pre-paid Business Reply Envelopes (BRE).

SEBI restriction on transfer of physical shares

SEBI vide its Notification no. SEBI/ LAD-NRO/GN/2018/24 has notified that with effect from December 5, 2018, except in case of transmission or transposition of securities, requests for effecting the transfer of securities shall not be processed unless the securities are held in the dematerialized form with a depository. Listing Regulations are appropriately amended to this effect.

In other words, there will not be any transfer of physical shares after 5 Dec 2018.

The said measure of SEBI is aimed at curbing fraud and manipulation risk in physical transfer of securities by unscrupulous entities. Transfer of securities only in demat form will improve ease, convenience and safety of transactions for investors.

Shareholders who continue to hold shares in physical form are advised to dematerialize their shares at the earliest. For any clarification, assistance or information relating to dematerialization of shares – members may contact the Company’s RTA.

Nodal Officer for IEPF

Ms. Manjula Ramamurthy
Company Secretary
Strides Pharma Science Limited
Bangalore – 560 076
Ph: +91 80 6784 0734
Mob: +91 9880667807
Email:
Manjula.r@strides.com
investors@strides.com